Estimating the cost of chronic kidney disease in Australia
These findings highlight the significant cost burden of CKD. While CKD costs per individual are highest in later stages, the greater number of early-stage CKD cases means the majority of the cost burden is located among early-stage cases. Primary and secondary prevention strategies are likely key to reducing costs.
Authors
- Sean Randall (ORCID: https://orcid.org/0000-0002-2756-5090)
- Aron Chakera (ORCID: https://orcid.org/0000-0003-3369-4187)
- Kanika Mehta (ORCID: https://orcid.org/0000-0002-0678-1165)
- Kevin Chai (ORCID: https://orcid.org/0000-0003-1645-0922)
- Elizabeth Thomas (ORCID: https://orcid.org/0000-0003-2054-872X)
- Crystal Lee (ORCID: https://orcid.org/0000-0001-6613-5491)
- James Boyd (ORCID: https://orcid.org/0000-0002-8925-8811)
- Narelle Hadlow (ORCID: https://orcid.org/0000-0003-0364-1850)
- Suzanne Robinson (ORCID: https://orcid.org/0000-0001-5703-6475)
- Ashley Irish (ORCID: https://orcid.org/0000-0002-9577-3764)
- Richard Varhol (ORCID: https://orcid.org/0000-0003-3608-400X)
- Delia Hendrie (ORCID: https://orcid.org/0000-0001-5022-5281)
- Johan Conradie
Institutions
- Baker Heart and Diabetes Institute (AU)
- Deakin University (AU)
- La Trobe University (AU)
- Curtin University (AU)
- Sir Charles Gairdner Hospital (AU)
- WA Country Health Service (AU)
- Pathwest Laboratory Medicine (AU)
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1186/s12913-024-11953-6
- Citations
- 3
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 1.02
Funders
- Australian Government
- Curtin University of Technology